RU2006141653A - Доставка противогрибковых лекарственных средств - Google Patents

Доставка противогрибковых лекарственных средств Download PDF

Info

Publication number
RU2006141653A
RU2006141653A RU2006141653/15A RU2006141653A RU2006141653A RU 2006141653 A RU2006141653 A RU 2006141653A RU 2006141653/15 A RU2006141653/15 A RU 2006141653/15A RU 2006141653 A RU2006141653 A RU 2006141653A RU 2006141653 A RU2006141653 A RU 2006141653A
Authority
RU
Russia
Prior art keywords
antifungal
concentration
antifungal composition
compound
composition according
Prior art date
Application number
RU2006141653/15A
Other languages
English (en)
Russian (ru)
Inventor
Марсель НИМНИ (US)
Марсель НИМНИ
Анант ПАНДЬЯ (GB)
Анант ПАНДЬЯ
Original Assignee
Марсель НИМНИ (US)
Марсель НИМНИ
Анант ПАНДЬЯ (GB)
Анант ПАНДЬЯ
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Марсель НИМНИ (US), Марсель НИМНИ, Анант ПАНДЬЯ (GB), Анант ПАНДЬЯ filed Critical Марсель НИМНИ (US)
Publication of RU2006141653A publication Critical patent/RU2006141653A/ru

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A61K31/343Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide condensed with a carbocyclic ring, e.g. coumaran, bufuralol, befunolol, clobenfurol, amiodarone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/13Amines
    • A61K31/135Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/41641,3-Diazoles
    • A61K31/4174Arylalkylimidazoles, e.g. oxymetazolin, naphazoline, miconazole
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/496Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0014Skin, i.e. galenical aspects of topical compositions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10Antimycotics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Emergency Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Dermatology (AREA)
  • Organic Chemistry (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
RU2006141653/15A 2004-04-27 2005-04-25 Доставка противогрибковых лекарственных средств RU2006141653A (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US10/832,933 US20050238672A1 (en) 2004-04-27 2004-04-27 Antifungal drug delivery
US10/832,933 2004-04-27

Publications (1)

Publication Number Publication Date
RU2006141653A true RU2006141653A (ru) 2008-06-10

Family

ID=35136720

Family Applications (1)

Application Number Title Priority Date Filing Date
RU2006141653/15A RU2006141653A (ru) 2004-04-27 2005-04-25 Доставка противогрибковых лекарственных средств

Country Status (14)

Country Link
US (1) US20050238672A1 (https=)
EP (1) EP1755575A4 (https=)
JP (1) JP2007534764A (https=)
KR (1) KR20070024543A (https=)
CN (1) CN101022779B (https=)
AU (1) AU2005237541A1 (https=)
BR (1) BRPI0510286A (https=)
CA (1) CA2564134A1 (https=)
IL (1) IL178750A0 (https=)
MX (1) MXPA06012426A (https=)
NO (1) NO20065422L (https=)
RU (1) RU2006141653A (https=)
WO (1) WO2005105072A2 (https=)
ZA (1) ZA200609821B (https=)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2699653C1 (ru) * 2019-03-22 2019-09-09 федеральное государственное автономное образовательное учреждение высшего образования Первый Московский государственный медицинский университет имени И.М. Сеченова Министерства здравоохранения Российской Федерации (Сеченовский университет) (ФГАОУ ВО Первый МГМУ им. И.М. Сеченова Минздрава России (Се Средство для лечения микоза ногтей

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0506139D0 (en) * 2005-03-24 2005-05-04 Transphase Ltd A transdermal topical composition and its uses
MXPA05012961A (es) * 2005-11-30 2007-05-30 Fernando Ahumada Ayala Preparaciones para el cuidado de las unas que contienen clorhidrato de terbinafina.
WO2007098591A2 (en) * 2006-03-02 2007-09-07 Nuvo Research Inc. Topical nail formulation
US20100168233A1 (en) * 2007-02-21 2010-07-01 Power Paper Ltd Terbinafine formulation
GB201011212D0 (en) * 2010-07-02 2010-08-18 Linde Aktiengesellshcaft Gas storage apparatus
KR20120056314A (ko) * 2010-11-24 2012-06-04 주식회사유한양행 테르비나핀 또는 그의 염을 함유하는 국소 항진균 조성물
US10302630B2 (en) 2012-10-09 2019-05-28 The Procter & Gamble Company Method of identifying or evaluating beneficial actives and compositions containing the same
JP6189962B2 (ja) 2012-10-09 2017-08-30 ザ プロクター アンド ギャンブル カンパニー 相乗作用する美容成分の組み合わせを特定する方法
US8697753B1 (en) 2013-02-07 2014-04-15 Polichem Sa Method of treating onychomycosis
US9144538B2 (en) 2013-02-08 2015-09-29 The Procter & Gamble Company Cosmetic compositions containing substituted azole and methods for alleviating the signs of photoaged skin
US9138393B2 (en) 2013-02-08 2015-09-22 The Procter & Gamble Company Cosmetic compositions containing substituted azole and methods for improving the appearance of aging skin
GB201317005D0 (en) * 2013-09-25 2013-11-06 Blueberry Therapeutics Ltd Composition and methods of treatment
EP2952208A1 (en) * 2014-06-04 2015-12-09 Universidade de Santiago de Compostela Hydroalcoholic system for nail treatment
CN109862882A (zh) * 2016-08-29 2019-06-07 卡尔·F·尚巴赫 用于治疗皮肤真菌感染的方法和组合物
US11554108B2 (en) 2016-08-29 2023-01-17 Xeropedix, Inc. Methods and compositions for treating cutaneous fungal infections
WO2021072027A1 (en) * 2019-10-08 2021-04-15 Hallux Inc. Onychomycosis treatment compositions and methods

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3382151A (en) * 1964-01-13 1968-05-07 Mavala Sa Composition for strengthening nails
DE3544983A1 (de) * 1985-12-19 1987-06-25 Hoechst Ag Antimykotisch wirksamer nagellack
US4820724A (en) * 1986-03-31 1989-04-11 University Of Southern California Dual phase solvent carrier system
US4894375A (en) * 1986-09-29 1990-01-16 Merck & Co., Inc. Method of controlling mycotic infections and compositions therefor
FR2673537B1 (fr) * 1991-03-08 1993-06-11 Oreal Utilisation d'agents de penetration hydrophiles dans les compositions dermatologiques pour le traitement des onychomycoses, et compositions correspondantes.
US5487776A (en) * 1994-03-17 1996-01-30 Nimni; Marcel Anti-fungal nail lacquer and method therefor
US5696164A (en) * 1994-12-22 1997-12-09 Johnson & Johnson Consumer Products, Inc. Antifungal treatment of nails
US5652256A (en) * 1995-06-06 1997-07-29 Knowles; W. Roy Topical composition for fungal treatment
US5814308A (en) * 1996-03-26 1998-09-29 Zhang; Ke Methods for the treatment of gastrointestinal tract disorders
US6030948A (en) * 1997-12-19 2000-02-29 Mann; Morris A. Hair regeneration compositions for treatment of alopecia and methods of application related thereto
CA2278328C (en) * 1998-02-09 2008-07-22 Macrochem Corporation Antifungal nail lacquer and method using same
CA2325553A1 (en) * 1998-04-17 1999-10-28 Penederm Inc. Topical formulations for the treatment of nail fungal diseases
US6495124B1 (en) * 2000-02-14 2002-12-17 Macrochem Corporation Antifungal nail lacquer and method using same
US6281239B1 (en) * 2000-04-12 2001-08-28 Bradley Pharmeaceuticals, Inc. Method of treating onychomycosis
US6585963B1 (en) * 2001-02-15 2003-07-01 Watson Pharmaceuticals, Inc. Nail compositions and methods of administering same
GB0108082D0 (en) * 2001-03-30 2001-05-23 Novartis Consumer Health Sa Topical composition
US6765001B2 (en) * 2001-12-21 2004-07-20 Medicis Pharmaceutical Corporation Compositions and methods for enhancing corticosteroid delivery
EP1635770B1 (en) * 2003-03-21 2009-05-27 Nexmed Holdings, Inc. Antifungal nail coat and method of use
US20040191207A1 (en) * 2003-03-31 2004-09-30 Lipari John M. Alpha-hydroxy acid ester drug delivery compositions and methods of use
HUP0303313A2 (hu) * 2003-10-09 2005-07-28 Richter Gedeon Vegyészeti Gyár Rt. Transzdermális gyógyszerkészítmények

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2699653C1 (ru) * 2019-03-22 2019-09-09 федеральное государственное автономное образовательное учреждение высшего образования Первый Московский государственный медицинский университет имени И.М. Сеченова Министерства здравоохранения Российской Федерации (Сеченовский университет) (ФГАОУ ВО Первый МГМУ им. И.М. Сеченова Минздрава России (Се Средство для лечения микоза ногтей

Also Published As

Publication number Publication date
CN101022779B (zh) 2010-12-08
CA2564134A1 (en) 2005-11-10
WO2005105072A2 (en) 2005-11-10
BRPI0510286A (pt) 2007-10-30
IL178750A0 (en) 2007-05-15
ZA200609821B (en) 2008-06-25
EP1755575A2 (en) 2007-02-28
CN101022779A (zh) 2007-08-22
KR20070024543A (ko) 2007-03-02
JP2007534764A (ja) 2007-11-29
MXPA06012426A (es) 2007-03-28
NO20065422L (no) 2007-01-19
AU2005237541A1 (en) 2005-11-10
EP1755575A4 (en) 2010-09-22
US20050238672A1 (en) 2005-10-27
WO2005105072A3 (en) 2006-03-02

Similar Documents

Publication Publication Date Title
RU2006141653A (ru) Доставка противогрибковых лекарственных средств
EP2005958B1 (en) External pharmaceutical composition
DK2512479T3 (en) Compositions for the treatment of peripheral vascular disease
JP2007534764A5 (https=)
RU2419429C2 (ru) Фармацевтическая композиция для наружного применения
US9056843B2 (en) Trifluoromethyl-oxadiazole derivatives and their use in the treatment of disease
WO2015051183A1 (en) Stabilized efinaconazole compositions
ZA200403035B (en) Imidazole-4-carboxamide derivatives, preparation and use thereof for treatment of obesity.
JP2017536382A5 (https=)
CN112105601A (zh) 作为细胞死亡抑制剂用于治疗例如卒中的3-(苄基氨基)-4-(环己基氨基)-n-(2-哌嗪-1-基)乙基)苯磺酰胺衍生物和相关的ferrostatin-1类似物
Carmignani et al. Novel hypotensive agents from Verbesina c aracasana. 8. Synthesis and pharmacology of (3, 4-Dimethoxycinnamoyl)-N-agmatine and Synthetic Analogues1
RU2006128445A (ru) Ацетилиновые пиперазиновые соединения и их применение в качестве антагонистов метаботропных глутаматных рецепторов
WO2015106283A1 (en) Antifungal compounds
US10537549B2 (en) Dihydroisoxazole compound for use in controlling sea lice
Mishra et al. Chemistry and pharmacology of luliconazole (imidazole derivative): a novel bioactive compound to treat fungal infection-a mini review
ZA200505037B (en) Pyridinalkyl-Aminoalkyl-1H-indole Derivatives having an Inhibitory Action on 5-HT and Serotonin Reuptake as Antidepressants and Anxiolytics
NO20050279D0 (no) Ny fremgangsmate
WO2010132852A2 (en) Protease inhibitors
KR101733189B1 (ko) 손톱 또는 발톱 성장 촉진용 조성물
KR101525019B1 (ko) Nrf2 활성화능을 갖는 신규 화합물, 이를 포함하는 약학적 조성물
US20080249088A1 (en) Topical Delivery of Antifungal Drugs
JP2008531526A (ja) 腎臓病の予防または治療に有用な薬物を調製するためのピラゾール誘導体の使用
CN101778828A (zh) 唑基亚甲基肼衍生物及其用途
EP2377855A1 (en) A valsartanamide dinitrate derivative for the treatment of vascular and metabolic diseases

Legal Events

Date Code Title Description
FA93 Acknowledgement of application withdrawn (no request for examination)

Effective date: 20080707

FZ9A Application not withdrawn (correction of the notice of withdrawal)

Effective date: 20080716

FA92 Acknowledgement of application withdrawn (lack of supplementary materials submitted)

Effective date: 20090811